Naval Medical Research Center: Research and Development of Protective Vaccines and Other Countermeasures Against Infectious Disease Agents of Military Importance

archived

Please note that NMLC established a cutoff date and time for questions of 10 July 2017 at 3:00 PM Local Time. NMLC is answering questions as fast as possible and the first set of Questions and Answers has been posted as an attachment under "Related Documents". This sheet will be continuously updated, so please check the attachment frequently. The intent of this award is to fund an organization that can provide collaborative assistance with manpower (scientists, research associates, research assistants, laboratory aides , nurses, clinical trials staff, program managers, and technicians), materiel (research supplies, equipment), and clinical trials (research subject compensation) for research efforts focusing on the development and evaluation of preventive and therapeutic countermeasures for P. falciparum and P. vivax malaria, bacterial causes of infectious diarrhea, rickettsial pathogens, emerging viral pathogens including dengue, MERS-CoV, Chikungunya, Zika, novel flu viruses and multi-drug resistant bacteria. The award will be issued as a cooperative agreement between the recipient and the Government (the Infectious Diseases Directorate, Naval Medical Research Center [IDD-NMRC]). The award recipient (awardee) will collaborate with IDD-NMRC to develop and implement scientific research efforts and share substantial programmatic involvement with IDD-NMRC.

High